Israel Englander Millennium Management
Israel “Izzy” Englander is the founder of Millennium Management, one of the world’s largest multi-strategy hedge fund platforms. Millennium allocates capital across hundreds of independent teams rather than a single house view, with rigorous risk controls at the platform level. Englander’s model has been highly influential in the rise of pod-shop multi-manager structures across the industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco QQQ Trust
QQQ
|
+$517M |
| 2 |
NXP Semiconductors
NXPI
|
+$351M |
| 3 |
Oracle
ORCL
|
+$279M |
| 4 |
Palo Alto Networks
PANW
|
+$268M |
| 5 |
Boston Scientific
BSX
|
+$204M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CERN
Cerner Corp
CERN
|
+$517M |
| 2 |
ExxonMobil
XOM
|
+$385M |
| 3 |
Cenovus Energy
CVE
|
+$292M |
| 4 |
PLAN
Anaplan, Inc.
PLAN
|
+$236M |
| 5 |
Phillips 66
PSX
|
+$222M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 55.01% |
| 2 | Technology | 7.76% |
| 3 | Financials | 7.66% |
| 4 | Healthcare | 7.12% |
| 5 | Industrials | 5.11% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
BOAS
3026
DELISTED
BOA Acquisition Corp.
BOAS
| $3.81M | ﹤0.01% |
389,289
+59,157
| +18% | +$583K |
|
3027
Viking Therapeutics
VKTX
$3.75B
| $3.8M | ﹤0.01% |
1,314,756
-187,130
| -12% | -$463K |
|
|
CNH
3028
CNH Industrial
CNH
$18.8B
| $3.8M | ﹤0.01% |
327,837
-428,954
| -57% | -$6.11M |
|
3029
Montauk Renewables
MNTK
$252M
| $3.8M | ﹤0.01% |
377,688
-296,586
| -44% | -$3.53M |
|
|
AMRN
3030
Amarin Corp
AMRN
$295M
| $3.79M | ﹤0.01% |
127,341
-116,928
| -48% | -$5.04M |
|
3031
ArcBest
ARCB
$3.05B
| $3.79M | ﹤0.01% |
53,875
+9,944
| +23% | +$731K |
|
|
KSI
3032
DELISTED
Kadem Sustainable Impact Corporation Class A common stock
KSI
| $3.79M | ﹤0.01% |
388,790
+1,000
| +0.3% | +$9.76K |
|
3033
Rayonier
RYN
$6.06B
| $3.79M | ﹤0.01% |
111,657
+98,628
| +757% | +$3.61M |
|
|
AVID
3034
DELISTED
Avid Technology Inc
AVID
| $3.79M | ﹤0.01% |
145,912
-663,668
| -82% | -$19.3M |
|
3035
Precigen
PGEN
$2.49B
| $3.78M | ﹤0.01% |
2,824,171
-2,109,264
| -43% | -$3.13M |
|
3036
CALL
iRhythm Holdings
IRTC
$3.96B
| $3.78M | ﹤0.01% |
+35,000
| New | +$4.64M |
|
3037
Illinois Tool Works
ITW
$79.8B
| $3.78M | ﹤0.01% |
20,731
+1,042
| +5% | +$208K |
|
|
GIAC
3038
DELISTED
Gesher I Acquisition Corp. Class A Ordinary Shares
GIAC
| $3.78M | ﹤0.01% |
383,350
+358,765
| +1,459% | +$3.54M |
|
3039
CTS Corp
CTS
$1.62B
| $3.77M | ﹤0.01% |
+110,780
| New | +$4.01M |
|
3040
CALL
TE Connectivity
TEL
$58.7B
| $3.77M | ﹤0.01% |
+33,300
| New | +$4.12M |
|
|
CND
3041
DELISTED
Concord Acquisition Corp.
CND
| $3.77M | ﹤0.01% |
378,058
-136,942
| -27% | -$1.36M |
|
3042
Ooma
OOMA
$629M
| $3.76M | ﹤0.01% |
317,809
+156,443
| +97% | +$2.08M |
|
3043
CALL
Global Payments
GPN
$24.3B
| $3.76M | ﹤0.01% |
34,000
| – | – |
|
3044
Kodiak Sciences
KOD
$2.37B
| $3.76M | ﹤0.01% |
492,383
-563,347
| -53% | -$3.96M |
|
3045
PUT
Weyerhaeuser
WY
$17B
| $3.76M | ﹤0.01% |
113,600
-43,200
| -28% | -$1.65M |
|
3046
Vera Therapeutics
VERA
$2.46B
| $3.76M | ﹤0.01% |
276,243
+142,743
| +107% | +$2.49M |
|
3047
Granite Construction
GVA
$5.44B
| $3.76M | ﹤0.01% |
128,972
-45,269
| -26% | -$1.41M |
|
3048
Seres Therapeutics
MCRB
$51.3M
| $3.75M | ﹤0.01% |
54,696
+25,232
| +86% | +$2.17M |
|
3049
CALL
Labcorp
LH
$27.2B
| $3.75M | ﹤0.01% |
+18,624
| New | +$3.97M |
|
|
ZINGU
3050
DELISTED
FTAC Zeus Acquisition Corp. Unit
ZINGU
| $3.75M | ﹤0.01% |
374,990
-125,010
| -25% | -$1.25M |
|
Similar funds
Israel Englander's Q2 2022 Portfolio in Review
As of Q2 2022, Israel Englander held 7,971 positions worth $161B, down 15% from $189B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
Israel Englander deployed $8.78B of net new capital in Q2 2022, opening 1,144 new positions and adding to 2,588 existing holdings. Its largest new stake was M&T Bank: 828,809 shares worth $132M.
By sector, the portfolio is most concentrated in Miscellaneous at 55% of assets, down from 60% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was ExxonMobil, an estimated $385M trimmed.
- Israel Englander's largest Q2 2022 buy was M&T Bank: 828,809 shares worth $132M.
- Israel Englander added most to Invesco QQQ Trust in Q2 2022, an estimated $517M increase.
- Israel Englander's biggest Q2 2022 reduction was ExxonMobil, cutting an estimated $385M.
- Israel Englander fully exited Cerner Corp in Q2 2022, selling an estimated $517M.
- Israel Englander's ten largest holdings make up 23% of its $161B portfolio in Q2 2022.
- Israel Englander opened 1,144 new positions and closed 1,065 in Q2 2022.
- Israel Englander's portfolio value fell 15% quarter-over-quarter to $161B.
Based on Millennium Management's 13F filing for Q2 2022, filed 15 Aug 2022.